Hundreds of people in the UK have reported problems with their pancreas linked to taking weight loss and diabetes injections, ...

The UK is studying cases of pancreatitis in people taking drugs based on GLP-1 receptor agonists for weight loss or type 2 ...

The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to ...

The medication, Mounjaro, is also known as tirzepatide and manufactured by Lilly. It is expected to be made available to approximately 220,000 individuals identified as having the "greatest need ...

Mounjaro has now become available on the NHS for patients in the UK, meaning doctors will have a lot more work on their ...

Weight loss drugs Mounjaro and Wegovy, as well as diabetes jab Ozempic may be linked to life-threatening health problems ...

And although the focus here is on implementation, it’s worth remembering what’s at stake. Obesity-related conditions like type 2 diabetes and cardiovascular disease already place a huge burden on the ...

Currently, those who can get the weight loss jab from the GP or community clinic in England need to have a BMI of 40 and over ...

In total, there have been 10 deaths linked to the drugs, as Professor Matt Brown, the chief scientific officer of Genomics ...

NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.

The UK is investigating a rise in acute pancreatitis cases linked to GLP-1 weight-loss drugs, exploring possible genetic ...

The UK must provide better funding opportunities for research and development across the regions if ambition is going to be ...